Oppenheimer Reiterates Outperform on Modular Medical, Maintains $3.5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Steven Lichtman has reiterated an Outperform rating on Modular Medical (NASDAQ:MODD) and maintained a price target of $3.5.
September 19, 2023 | 11:57 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst has reiterated an Outperform rating on Modular Medical and maintained a price target of $3.5.
The reiteration of an Outperform rating by an Oppenheimer analyst indicates a positive outlook for the company. The maintained price target of $3.5 also suggests that the analyst believes the stock is currently undervalued, which could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100